Palisade Bio Inc — Quarterly Financial Statistics (NASDAQ:PALI)

Financials

Cash from operating activities 3.13 M2.38 M2.33 M1.82 M3.55 M 10.08 M Cash from investing activities ————— — Cash from financing activities -180 K4.16 M258 K-4 0002.85 M 7.27 M Free cash flow 3.13 M2.38 M2.33 M1.82 M3.55 M 10.08 M

新闻

Stifel首次覆盖Palisade Bio股票,基于IBD药物给予买入评级

Stifel initiates Palisade Bio stock with buy rating on IBD drug

Palisade Bio在ECCO大会上展示溃疡性结肠炎药物试验数据

Palisade Bio presents ulcerative colitis drug trial data at ECCO

Palisade Bio appoints IBD expert to clinical advisory board

Palisade Bio (PALI) 首席医疗官Jones出售价值$3480的股票

Palisade Bio首席执行官Finley出售价值$6818的股份

Palisade Bio任命两位IBD专家加入临床顾问委员会

Palisade Bio appoints two IBD experts to clinical advisory board

Palisade Bio董事Williams以每股1.88美元购入价值9,400美元股票

Palisade Bio director Williams buys $9,400 in shares

B.Riley 以买入评级开始对 Palisade Bio 股票进行覆盖